KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A * 11 while diminishing avidity for HLA-C
about
The shaping of modern human immune systems by multiregional admixture with archaic humansGenome hyperevolution and the success of a parasiteThe Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptorsCo-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan AfricansCoevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cellsCanonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4.KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell functionImputation of KIR Types from SNP Variation Data.Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice.Self-association of an activating natural killer cell receptor, KIR2DS1Primate-specific regulation of natural killer cells.DAP12 impacts trafficking and surface stability of killer immunoglobulin-like receptors on natural killer cellsSignificant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA.Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.KIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand.Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation.Balancing natural killer cell activation through paired receptors.Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples.The structural basis of ligand recognition by natural killer cell receptors.Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class IKiller-cell immunoglobulin-like receptor genotyping and HLA killer-cell immunoglobulin-like receptor-ligand identification by real-time polymerase chain reactionKIR2DS5 in the presence of HLA-C C2 protects against endometriosisAnalysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infectionHow does variability of immune system genes affect placentation?Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.Revealing mammalian evolutionary relationships by comparative analysis of gene clustersMutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.Structural insights into activation of antiviral NK cell responsesGenetic (KIR, HLA-C) and Some Clinical Parameters Influencing the Level of Liver Enzymes and Early Virologic Response in Patients with Chronic Hepatitis CConserved KIR allele-level haplotypes are altered by microvariation in individuals with European ancestry.Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms.Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactorAnalysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies.The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the Polish population.
P2860
Q22065603-C3D97BEE-0208-428E-9EE7-95D4CF16B176Q24630129-E19FBE3D-C17B-499E-B6E0-DC499855AFD7Q26742135-B977D5F9-34CB-4406-951E-E184B8FBCFCAQ26776114-A360D222-D3D9-4751-9044-C2989F3A5CC9Q27681802-D7DADDA9-12C7-4565-B222-292155ACA025Q28298119-D3C25285-4DAF-450D-86EB-1569169E7A02Q28534758-D03D8786-F5F5-4818-B49C-63047FECE8D0Q28743223-D88F43C5-94C6-49A6-BC2E-8E777E204473Q30252783-F2505190-DA18-43F0-A9FF-836823B66CA8Q30372604-E37C8B71-84F0-49E5-9DDC-12BD27A7F256Q30829234-CFDC6216-93AB-474B-AFB8-0F01C3CBE0E0Q31000729-D35CEFDE-1339-4A45-8CA7-4D52A5AD5B94Q33594882-7FBAD2CE-A2C5-4906-BF8C-E6732CC2B348Q34017545-EA34B98B-9C7E-4FDC-8660-51CA78903ABDQ34064807-4C388DC3-5E6F-47E1-ABB7-3B0D7F5A7CA3Q34156998-03AD8219-75DF-465F-9769-D6FEC16FD09AQ34192841-D2541C75-018E-45D7-B014-AFCB21DD569DQ34245469-EBDEDDC5-EC68-48C4-959F-E144E3D01FAAQ34345310-992473A7-8C76-4C97-9ABB-3D19676DFA95Q34362162-CDD0DE5D-0293-40B4-823F-4DAE7EE1F4CDQ34427302-A3BC8E98-E653-4760-B5F7-D13880277700Q34465877-D5BFA1D7-988C-4A4D-B61E-CB9352E8FFBDQ34764350-4BB02817-75E4-4B8B-89D7-EB9453F82412Q35001148-8344A281-8CE7-4436-872E-07CF246A7640Q35071326-2164533E-5139-40DF-8F13-133C9832551CQ35148027-E95AA91C-2E73-42A5-963A-477390224258Q35171437-503B98F9-A6C4-41DA-9129-0B1116DA52B1Q35175810-795BC7DE-3B59-4047-84CF-5977795D4491Q35421157-D3E19E7A-67D9-4B8B-8E4F-A357051ACC9DQ35456420-77C7FDE6-AAFE-45B0-8897-F359B7D98823Q35701077-55D6A5F3-50A9-417F-8B80-171B97AC0B5BQ35930303-B0A30440-E822-4C1D-A901-76214CC1B37BQ36227213-7DF8C67C-BF09-4998-B8F1-B4CBFFB772CBQ36317668-82AE401F-78BB-4649-B013-8B816147CEF3Q36465097-0324757B-FE96-4A96-A4F4-8149B5637B05Q36505826-D86545F4-7781-422B-9E7A-A6A5DE7BE300Q36569959-FABAD685-8C93-4E82-8E6F-952AC80EEA6DQ36626424-C510DB7D-2999-4F84-8B4A-68A1971DDA56Q36750477-4B9FA85E-1892-4BD2-8228-F9D93540FC7CQ36828738-90CFDFE5-258C-4102-81A8-93670CD48A8C
P2860
KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A * 11 while diminishing avidity for HLA-C
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
KIR2DS4 is a product of gene c ...... diminishing avidity for HLA-C
@ast
KIR2DS4 is a product of gene c ...... diminishing avidity for HLA-C
@en
KIR2DS4 is a product of gene c ...... diminishing avidity for HLA-C
@nl
type
label
KIR2DS4 is a product of gene c ...... diminishing avidity for HLA-C
@ast
KIR2DS4 is a product of gene c ...... diminishing avidity for HLA-C
@en
KIR2DS4 is a product of gene c ...... diminishing avidity for HLA-C
@nl
prefLabel
KIR2DS4 is a product of gene c ...... diminishing avidity for HLA-C
@ast
KIR2DS4 is a product of gene c ...... diminishing avidity for HLA-C
@en
KIR2DS4 is a product of gene c ...... diminishing avidity for HLA-C
@nl
P2093
P2860
P50
P3181
P356
P1476
KIR2DS4 is a product of gene c ...... diminishing avidity for HLA-C
@en
P2093
Anastazia M Older Aguilar
David A Bushnell
John A Hammond
Laurent Abi-Rached
Lisbeth A Guethlein
Michael Gleimer
Peter Parham
Philip J Robinson
Thorsten Graef
P2860
P304
P3181
P356
10.1084/JEM.20091010
P407
P577
2009-10-01T00:00:00Z